Editorial
 FLAGRANT VIOLATION OF RULES   
 Wednesday, April 17, 2019 
 Recently, there were two scathing reports in Pharmabiz exposing the flagrant violation of drug laws in Bihar and Odisha due to the totally indifferent attitude of the state drug control administrations of these states. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Oakrum Pharma enters agreement with Biophore India Pharma to develop & manufacture two prescription generic pharma products
17:00  [IST]US FDA approves first generic naloxone nasal spray to treat opioid overdose
16:10  [IST]AI start-up mfine raises US$ 17.2 million in Series B; to create largest virtual healthcare delivery network
16:00  [IST]Quest Diagnostics introduces new consumer-initiated STD tests through QuestDirect
15:00  [IST]Lilly to sell legacy antibiotics brands, Ceclor & Vancocin and China plant to Eddingpharm
14:00  [IST]Europe-Africa partnership spearheads development of next-generation antimalarial drug
more news >>
TOP NEWS
08:00  [IST]Health ministry to amend Rule 66 of D&C Rules to authorise state DCs to issue stop sale order for non-compliance
08:00  [IST]Regulators & pharmacists demand revocation of Schedule K (5) to make registered pharmacists sole authority to keep & sell medicines
08:00  [IST]Interface eyes Indian pharma to switch from vinyl to rubber floors as an environment-friendly & cost-effective option
08:00  [IST]AP and TS have highest prevalence of adult HIV cases in India, reveals NACO report
08:00  [IST]Indian pharma market grew by 8.9% in March 2019 to Rs. 10,876 crore
08:00  [IST]CDSCO to regulate all non-notified medical devices in phased manner to ensure patient safety
more news >>
YESTERDAY'S NEWS
18:00  [IST]Intra-Cellular's Sharon Mates, CRF Bracket’s David Daniel & Gary Sachs are recipients of 2019 ISCDD Scientific Leadership Awards
17:00  [IST]Systech promotes Jefferson Barr to VP of global marketing
16:50  [IST]Health Minister reviews progress of Ayushman Bharat-PMJAY
16:00  [IST]Innovent doses first patient in phase I trial of IBI302 for wet AMD treatment
15:00  [IST]Pfizer, Lilly announce positive results from phase 3 study of tanezumab in patients with osteoarthritis
14:20  [IST]Sixth Sense Ventures invests US$ 3 million in MyHealthcare
more news >>
INTERVIEW  
Cyber security key in pharma and healthcare to ensure protection of information
Jaykishan Nirmal, senior vice president 113648interview
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
CPhI_Korea_2019_150x60
CPHI19_Banner-Ad_150x60
Small-Banner-Chandigarh
PharmaLytica150x60_2019
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |